Title |
Prescription of topiramate to treat alcohol use disorders in the Veterans Health Administration
|
---|---|
Published in |
Addiction Science & Clinical Practice, July 2013
|
DOI | 10.1186/1940-0640-8-12 |
Pubmed ID | |
Authors |
A C Del Re, Adam J Gordon, Anna Lembke, Alex HS Harris |
Abstract |
As a quality improvement metric, the US Veterans Health Administration (VHA) monitors the proportion of patients with alcohol use disorders (AUD) who receive FDA approved medications for alcohol dependence (naltrexone, acamprosate, and disulfiram). Evidence supporting the off-label use of the antiepileptic medication topiramate to treat alcohol dependence may be as strong as these approved medications. However, little is known about the extent to which topiramate is used in clinical practice. The goal of this study was to describe and examine the overall use, facility-level variation in use, and patient -level predictors of topiramate prescription for patients with AUD in the VHA. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Canada | 1 | 3% |
Unknown | 34 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 6 | 17% |
Other | 3 | 9% |
Student > Doctoral Student | 3 | 9% |
Student > Bachelor | 3 | 9% |
Professor | 3 | 9% |
Other | 6 | 17% |
Unknown | 11 | 31% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 11 | 31% |
Psychology | 4 | 11% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 3% |
Biochemistry, Genetics and Molecular Biology | 1 | 3% |
Nursing and Health Professions | 1 | 3% |
Other | 3 | 9% |
Unknown | 14 | 40% |